Wade Jeffrey L

Wade Jeffrey L is listed in filings as President and COO at Lexicon Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 8, 2024, including 1 public disclosure. Recent filings connect the profile to Lexicon Pharmaceuticals, Inc. (LXRX). The current snapshot covers public activity from Jul 8, 2024. Reported amounts are shown as $512.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.